#Jun O. Liu #Rapafusyn #Nai Fellow

Dr. Jun O. Liu Receives Prestigious NAI Fellowship

In a remarkable achievement for the field of biotechnology, Dr. Jun O. Liu, the founder of Rapafusyn Pharmaceuticals and a prominent researcher at Johns Hopkins University School of Medicine, has been honored with the title of Fellow by the National Academy of Inventors (NAI). This distinction stands as the highest professional accolade reserved specifically for academic inventors who have made significant contributions to innovation in science and technology.

The NAI Fellowship recognizes individuals whose inventive work has achieved noteworthy societal and economic implications, particularly in health innovation. Dr. Liu’s election highlights his outstanding contributions and prolific patent portfolio, firmly placing him among the leading figures in the academic innovation landscape. This honor reflects a rigorous selection process, which includes assessing the real-world impact of one's research, innovative capabilities, and the transformative potential of their inventions.

Dr. Liu has gained international recognition for his groundbreaking work in natural product chemistry and his pioneering research into drug mechanisms, particularly in the molecular glue domain. His notable discoveries date back to 1991 when he co-authored a pivotal study published in Cell. This research unveiled a revolutionary mode of action for the immunosuppressive drugs FK506 and cyclosporin A, demonstrating how these agents function by